Pols H, Zandergen J, de Loof C, Fernandez I, Griez E
Department of Clinical Psychiatry, State University of Limburg, Maastricht, The Netherlands.
Acta Psychiatr Belg. 1993 May-Jun;93(3):169-77.
In a double-blind randomized placebo-controlled cross-over design trial, the effects of a 4 week fluvoxamine versus a 4 week placebo treatment regimen on panic symptomatology were studied. Fluvoxamine seems to have specific antipanic properties, as a significant decrease in the number of panic attacks was observed. Other components of the disorder, like free-floating anxiety and avoidance behavior were not influenced during the short 4 week treatment period.
在一项双盲随机安慰剂对照交叉设计试验中，研究了4周氟伏沙明与4周安慰剂治疗方案对惊恐症状的影响。氟伏沙明似乎具有特定的抗惊恐特性，因为观察到惊恐发作次数显著减少。在为期4周的短疗程治疗期间，该疾病的其他组成部分，如漂浮性焦虑和回避行为并未受到影响。
